Product
MSB0010718C
1 clinical trial
1 indication
Indication
Breast NeoplasmsClinical trial
Adjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody Avelumab: A Phase III Randomized Trial. Sponsor: Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di PadovaStatus: Active (not recruiting), Estimated PCD: 2024-06-01